Related Experiment Videos
A 28-day feeding study with methyl isoeugenol in rats
R Purchase1, G P Ford, D M Creasy
1BIBRA Toxicology International, Carshalton, Surrey, UK.
Summary
Methyl isoeugenol administration in rodent diets showed no adverse effects on general health or growth. Minor increases in liver weight and white blood cell counts were observed but not considered toxicological concerns.
Area of Science:
- Toxicology
- Pharmacology
- Rodent Studies
Background:
- Methyl isoeugenol is a naturally occurring compound found in various essential oils.
- Understanding the toxicological profile of methyl isoeugenol is crucial for safety assessments.
Purpose of the Study:
- To evaluate the potential adverse effects of dietary methyl isoeugenol administration in Sprague-Dawley rats.
- To determine the no-observed-adverse-effect level (NOAEL) of methyl isoeugenol.
Main Methods:
- Rats (16 males, 16 females per group) were administered methyl isoeugenol in their diet at doses of 30, 100, or 300 mg/kg body weight/day for at least 28 days.
- Control groups received the standard rodent diet.
- Body weight, general health, food intake, hematology, serum chemistry, urinalysis, and histopathology were assessed.
Main Results:
- No adverse effects on growth, general health, or food intake were observed across all dose groups.
- Slight increases in liver weight and white blood cell counts (lymphocytes, total white blood cells) were noted in the high-dose (300 mg/kg) group.
- Minor variations in serum chemistry and urine analyses were not considered treatment-related.
- Histopathological examination revealed no significant treatment-related abnormalities, with observed kidney and Harderian gland lesions deemed spontaneous.
Conclusions:
- Dietary administration of methyl isoeugenol up to 300 mg/kg body weight/day did not induce significant adverse toxicological effects in rats.
- The observed increases in liver weight and white blood cell counts at the highest dose are not considered adverse effects.
- Methyl isoeugenol appears to have a favorable safety profile based on this 28-day rodent study.